1. |
Bartsch P, Swenson ER . Clinical practice: acute high-altitude illnesses. N Engl J Med 2013; 368(24):2294-302. doi: 10.1056/NEJMcp1214870.
|
2. |
Roach RC, Hackett PH, Oelz O , et al. The 2018 Lake Louise Acute Mountain Sickness Score. High Alt Med Biol 2018; 19(1):4-6. doi: 10.1089/ham.2017.0164.
|
3. |
Lu H, Wang R, Xiong J , et al. In search for better pharmacological prophylaxis for acute mountain sickness: looking in other directions. Acta Physiol (Oxf) 2015; 214(1):51-62. doi: 10.1111/apha.12490.
|
4. |
Kayser B, Verges S . Hypoxia, energy balance and obesity: from pathophysiological mechanisms to new treatment strategies. Obes Rev 2013; 14(7):579-92. doi: 10.1111/obr.12034.
|
5. |
Jin J . Acute mountain sickness. JAMA 2017; 318(18):1840. doi: 10.1001/jama.2017.16077.
|
6. |
Luks AM, Swenson ER, Bartsch P . Acute high-altitude sickness. Eur Respir Rev 2017; 26:160096. doi: 10.1183/16000617.0096-2016.
|
7. |
Basnyat B, Murdoch DR . High-altitude illness. Lancet 2003; 361(9373):1967-74. doi: 10.1016/S0140-6736(03)13591-X.
|
8. |
de Oliveira S, Rosowski EE, Huttenlocher A . Neutrophil migration in infection and wound repair: going forward in reverse. Nat Rev Immunol 2016; 16(6):378-91. doi: 10.1038/nri.2016.49.
|
9. |
Liu B, Chen J, Zhang L , et al. IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis. Front Immunol 2017; 8:628. doi: 10.3389/fimmu.2017.00628.
|
10. |
Eltzschig HK, Carmeliet P . Hypoxia and inflammation. N Engl J Med 2011; 364(7):656-65. doi: 10.1056/NEJMra0910283.
|
11. |
Hartmann G, Tschop M, Fischer R , et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 2000; 12(3):246-52. doi: 10.1006/cyto.1999.0533.
|
12. |
Boos CJ, Woods DR, Varias A , et al. High altitude and acute mountain sickness and changes in circulating Endothelin-1, Interleukin-6, and Interleukin-17a. High Alt Med Biol 2016; 17(1):25-31. doi: 10.1089/ham.2015.0098.
|
13. |
Hackett PH, Roach RC . High-altitude illness. N Engl J Med 2001; 345(2):107-14. doi: 10.1056/NEJM200107123450206.
|
14. |
Julian CG, Subudhi AW, Wilson MJ , et al. Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study. J Appl Physiol 2011; 111(2):392-9. doi: 10.1152/japplphysiol.00391.2011.
|
15. |
Bailey DM, Rimoldi SF, Rexhaj E , et al. Oxidative-nitrosative stress and systemic vascular function in highlanders with and without exaggerated hypoxemia. Chest 2013; 143(2):444-51. doi: 10.1378/chest.12-0728.
|
16. |
Irarrazaval S, Allard C, Campodonico J , et al. Oxidative stress in acute hypobaric hypoxia. High Alt Med Biol 2017; 18(2):128-34. doi: 10.1089/ham.2016.0119.
|
17. |
Bailey DM, Taudorf S, Berg RM , et al. Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness? Am J Physiol Regul Integr Comp Physiol 2009; 297(5):R1283-92. doi: 10.1152/ajpregu.00366.2009.
|
18. |
Diebel LN, Liberati DM, Taub JS , et al. Intestinal epithelial cells modulate PMN activation and apoptosis following bacterial and hypoxic challenges. J Trauma 2005; 58(6):1126-33. doi: 10.1097/01.ta.0000169952.50045.f4.
|
19. |
Kannan KB, Colorado I, Reino D , et al. Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2011; 300(5):G853-61. doi: 10.1152/ajpgi.00459.2010.
|
20. |
Kleessen B, Schroedl W, Stueck M , et al. Microbial and immunological responses relative to high-altitude exposure in mountaineers. Med Sci Sports Exerc 2005; 37(8):1313-8. doi: 10.1249/01.mss.0000174888.22930.e0.
|
21. |
Karl JP, Hatch AM, Arcidiacono SM , et al. Effects of psychological, environmental and physical stressors on the gut microbiota. Front Microbiol 2018; 9:2013. doi: 10.3389/fmicb.2018.02013.
|
22. |
Recavarren-Arce S, Ramirez-Ramos A, Gilman RH , et al. Severe gastritis in the Peruvian Andes. Histopathology 2005; 46(4):374-9. doi: 10.1111/j.1365-2559.2005.02102.x.
|
23. |
Wu TY, Ding SQ, Liu JL , et al. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol 2007; 8(2):88-107. doi: 10.1089/ham.2007.1015.
|
24. |
Zhang S, Wu T. Study on the relationship between systemic inflammatory response syndrome and acute mountain sickness syndrome. Med J NDFNC 2007; 28(2):81-3. Chinese. doi: 10.16021/j.cnki.1007-8622.2007.02.001.
|
25. |
Roach RC, Greene ER, Schoene RB , et al. Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med 1998; 69(12):1182-1185.
|
26. |
Anholm JD . The VIIIth World Congress of high altitude medicine and physiology, Arequipa, Peru, August 8-12, 2010. High Alt Med Biol 2010; 11(4):381-4. doi: 10.1089/ham.2010.1061.
|
27. |
Lipman GS, Kanaan NC, Holck PS , et al. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med 2012; 59(6):484-90. doi: 10.1016/j.annemergmed.2012.01.019.
|
28. |
Gertsch JH, Corbett B, Holck PS , et al. Altitude sickness in climbers and efficacy of NSAIDs trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness. Wilderness Environ Med 2012; 23(4):307-15. doi: 10.1016/j.wem.2012.08.001.
|
29. |
Basnyat B, Gertsch JH, Johnson EW , et al. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. High Alt Med Biol 2003; 4(1):45-52. doi: 10.1089/152702903321488979.
|